摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(2-fluoro-4-iodophenyl)morpholine | 1250999-09-7

中文名称
——
中文别名
——
英文名称
4-(2-fluoro-4-iodophenyl)morpholine
英文别名
——
4-(2-fluoro-4-iodophenyl)morpholine化学式
CAS
1250999-09-7
化学式
C10H11FINO
mdl
——
分子量
307.106
InChiKey
OPLXUSMUSYXUOG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    348.1±42.0 °C(Predicted)
  • 密度:
    1.715±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    12.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Oxazolidinone derivatives: Cytoxazone–Linezolid hybrids induces apoptosis and senescence in DU145 prostate cancer cells
    摘要:
    In this study, we report the synthesis of novel oxazolidinone derivatives derived from linezolid 3 having p-methoxyphenyl group at C-4 position. In vitro evaluation for their anticancer activity toward cultured A549, DU145, HELA, and MCF7 were carried out. The series of compounds prepared displayed wide range of cytotoxicity in MTT assays (10-70 μM) across the cell lines tested. Of the all tested compounds 16 and 17 displayed good anticancer potential against A549 (lung) and DU145 (prostate) cancer cells. Further, to determine their anticancer potential, in the present study we have assessed effect of 17 on DU145 cells growth in in vitro assays. The results clearly demonstrated that the exposure of DU145 cells to 17 inhibits cell proliferation and induces apoptosis by activation of caspase-3 and -9. Long term exposure of DU145 cells to 17 induced cellular senescence confirmed by senescence marker β-galactosidase staining of cells on post exposure to 17. The results from this current report support that the oxazolidinone derivatives with ethyl and acryl substitutions showed promising anticancer activity which will be helpful to develop further novel anticancer agents with better therapeutic potential.
    DOI:
    10.1016/j.ejmech.2014.04.062
  • 作为产物:
    参考文献:
    名称:
    镍催化芳基氨基磺酸盐的胺化
    摘要:
    范围广泛:芳基氨基磺酸盐是有吸引力的交叉偶联伙伴,特别是对于多步合成,是通过使用镍催化剂实现的。该方法提供了一种使用苯酚的简单衍生物作为多取代芳胺前体的通用方法,例如抗菌药物利奈唑胺的简明合成(参见方案)。
    DOI:
    10.1002/anie.201007325
点击查看最新优质反应信息

文献信息

  • [EN] SUBSTITUTED PHENYLOXAZOLIDINONES FOR ANTIMICROBIAL THERAPY<br/>[FR] PHENYL-OXAZOLIDINONES SUBSTITUÉES POUR LA THÉRAPIE ANTIMICROBIENNE
    申请人:THE GLOBAL ALLIANCE FOR TB DRUG DEV INC
    公开号:WO2017015106A1
    公开(公告)日:2017-01-26
    The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.
    本发明涉及新型噁唑烷酮(化学式I):或具有由含氮的单环、双环或螺环取代基特征的环A的药用盐,以及其制备方法,以及作为用于治疗结核分枝杆菌和其他微生物感染的药物的用途,可以单独使用或与其他抗感染治疗结合使用。
  • Amination of Aryl Alcohol Derivatives
    申请人:Garg Neil K.
    公开号:US20130289270A1
    公开(公告)日:2013-10-31
    Embodiments of the invention provide methods and materials for chemical cross-coupling reactions that utilize aryl alcohol derivatives as cross-coupling partners. Embodiments of the invention include methods for the amination of aryl sulfamates and carbamates, which are attractive cross-coupling partners, particularly for use in multistep synthesis. Illustrative embodiments include versatile means to use simple derivatives of phenol as precursors to polysubstituted aryl amines, as exemplified by a concise synthesis of the antibacterial drug linezolid.
    本发明的实施例提供了一种利用芳基醇衍生物作为交叉偶联反应的偶联反应方法和材料。本发明的实施例包括芳基磺酸酯和氨基甲酸酯的化方法,它们是有吸引力的交叉偶联反应伙伴,特别适用于多步合成。说明性实施例包括使用苯酚的简单衍生物作为多取代芳基胺的前体的多种方法,如紧凑的合成抗菌药物利奈唑胺的方法。
  • [EN] AMINATION OF ARYL ALCOHOL DERIVATIVES<br/>[FR] AMINATION DE DÉRIVÉS D'ALCOOL ARYLIQUE
    申请人:UNIV CALIFORNIA
    公开号:WO2012094622A3
    公开(公告)日:2012-10-18
  • US9567307B2
    申请人:——
    公开号:US9567307B2
    公开(公告)日:2017-02-14
查看更多